MedPath

A randomised controlled trial on the effectiveness of Sir John Kirwan's the Journal in secondary care treatment of patients with depression/dysthymia

Conditions
Depression
Dysthymia
Mental Health - Depression
Registration Number
ACTRN12613000015741
Lead Sponsor
niservices
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

Referral to Community Mental Health Team for depression/dysthymia

Exclusion Criteria

Inability to speak/understand English as participants are required to be able to operate a computer.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
PHQ-9 to measure severity of depressive symptoms[Baseline, 6, 12 weeks]
Secondary Outcome Measures
NameTimeMethod
SF-36 to measure function and well being[Baseline, 6, 12 weeks];EQ-5D to measure health-related quality of life that are related to costs.[Baseline, 6, 12 weeks. These tests will be completed at these time points.];Internet use[12 weeks by self report questionnaire];Cost of treatment. Outpatient appointments, hospital visits, medication use and time off will be monitored to determine this.[12 weeks]
© Copyright 2025. All Rights Reserved by MedPath